Lido Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,004
Closed -$532K 683
2020
Q1
$532K Buy
3,004
+61
+2% +$11.5K 0.02% 315
2019
Q4
$563K Sell
2,943
-5
-0.2% -$902 0.02% 359
2019
Q3
$496K Sell
2,948
-95
-3% -$15.5K 0.03% 334
2019
Q2
$509K Sell
3,043
-76
-2% -$10.5K 0.03% 299
2019
Q1
$456K Sell
3,119
-53
-2% -$7.68K 0.03% 301
2018
Q4
$423K Sell
3,172
-95
-3% -$15.6K 0.04% 254
2018
Q3
$622K Sell
3,267
-128
-4% -$23.5K 0.06% 197
2018
Q2
$566K Buy
3,395
+31
+0.9% +$4.98K 0.07% 175
2018
Q1
$566K Buy
3,364
+1,170
+53% +$196K 0.08% 167
2017
Q4
$358K Buy
+2,194
New +$394K 0.05% 201
2017
Q3
Sell
-1,127
Closed -$274K 341
2017
Q2
$274K Sell
1,127
-419
-27% -$98.5K 0.06% 195
2017
Q1
$374K Buy
1,546
+499
+48% +$116K 0.1% 127
2016
Q4
$220K Sell
1,047
-223
-18% -$46.2K 0.05% 180
2016
Q3
$292K Sell
1,270
-7
-0.5% -$1.71K 0.09% 105
2016
Q2
$295K Buy
1,277
+183
+17% +$42.2K 0.09% 112
2016
Q1
$293K Buy
+1,094
New +$313K 0.1% 98

Other funds holding AGN

Lido Advisors's AGN Position: Q2 2020 in Review

Lido Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,004 shares — an estimated $532K sold.

Lido Advisors first reported a position in AGN in Q1 2016 and held it in 16 quarters. The position peaked at $622K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Lido Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Lido Advisors sold 3,004 Allergan plc shares in Q2 2020, an estimated $532K.
  • Lido Advisors first reported a position in Allergan plc in Q1 2016 and held it in 16 quarters.
  • Lido Advisors's Allergan plc position peaked at $622K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Lido Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.